Stages I-II/ Anal Cancer News

Share


Recent Stages I-II/ Anal Cancer News


When Good Cells Go Bad (February 20, 2017)

By Kari Bohlke, ScD Cancer. The word has taken on a meaning that extends beyond the medical definition. Cancer is deadly; it is dangerous; it means bad news. But when we hear the words, “You have cancer,”... Continue Reading

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (February 20, 2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer... Continue Reading

Unique Gene Signature Predicts Potentially Lethal Prostate Cancers (February 18, 2017)

Standard therapy for prostate cancer, the third-leading cause of cancer-related deaths in American men, is based on blocking androgens, the male sex hormones. However, for some men, prostate cancer recurs... Continue Reading

Proton beam therapy may improve outcomes for pancreatic cancer (February 17, 2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for... Continue Reading

2016-Year in Review: Advances in Management of Lymphomas (February 16, 2017)

Our understanding of lymphomas has allowed scientists to find new and unique ways of treating this blood cancer. Lymphoma treatments have expanded far beyond chemotherapy, though that type of treatment... Continue Reading

2016-Year in Review: Advances in Management of Head and Neck Cancer (February 16, 2017)

Globally, head and neck cancer (HNC) comprises the seventh most common type of cancer with an estimated 400,000-600,000 diagnoses every year. 2016 saw significant advances in understanding the role of... Continue Reading

FDA Approves Opdivo for Treatment of Bladder Cancer (February 16, 2017)

The US Food and Drug Administration (FDA) today approved Opdivo, (nivolumab) for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed during a... Continue Reading

Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients (February 15, 2017)

Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Doctors at Moffitt Cancer Center in Tampa Florida... Continue Reading

Twice-daily radiation therapy reduces mortality from head and neck cancer (February 14, 2017)

Treating head and neck cancer patients with a twice-daily radiation therapy schedule combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress... Continue Reading

Recognizing the Early Signs of Anemia (February 9, 2017)

Anemia (an inadequate supply of red blood cells) can cause symptoms such as fatigue, shortness of breath, and dizziness. Other possible signs of this condition include rapid heartbeat, chest pain, difficulty... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS